Department of Natural Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People's Republic of China.
Bioorg Med Chem Lett. 2011 Feb 1;21(3):909-11. doi: 10.1016/j.bmcl.2010.12.080. Epub 2010 Dec 21.
Elaborate study on the three-dimensional model of α(1)-adrenoceptor (α(1)-AR) antagonists led to the development of a series of new arylpiperazine derivatives bearing a flavone nucleus as α(1)-AR antagonists. The in vitro activities were evaluated and compounds 1, 4, 10, 13 and 15 showed activities close to the reference compound (Prazosin).
对 α(1)-肾上腺素受体(α(1)-AR)拮抗剂的三维模型进行深入研究,开发了一系列新型芳基哌嗪衍生物,其具有黄酮核作为 α(1)-AR 拮抗剂。评估了它们的体外活性,化合物 1、4、10、13 和 15 表现出与参比化合物(哌唑嗪)相近的活性。